News
The Print on MSN20h
Govt considers low-dose emicizumab for haemophilia, trial finds it more effective than existing treatmentMiracle drug’ can cost Rs 13 lakh for haemophilia A patient annually, but reduced dose found efficacious & cost-effective in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback